Cargando…
Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells
Receptor for advanced glycation end products (RAGE) is critical in inflammatory diseases, including diabetes and atherosclerosis. The mechanism underlying the effect of peroxisome proliferator-activated receptor γ (PPARγ) agonist pioglitazone (PIO) on RAGE expression in coronary artery smooth muscle...
Autores principales: | DI, BEI-BING, LI, HONG-WEI, LI, WEI-PING, SHEN, XU-HUA, SUN, ZHI-JUN, WU, XING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337739/ https://www.ncbi.nlm.nih.gov/pubmed/25523934 http://dx.doi.org/10.3892/mmr.2014.3113 |
Ejemplares similares
-
Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling
por: Gao, Hongli, et al.
Publicado: (2017) -
Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
por: Mao, Lin, et al.
Publicado: (2022) -
Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes
por: Sun, Yongxin, et al.
Publicado: (2016) -
Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function
por: Simard, Elie, et al.
Publicado: (2015) -
Advanced Glycation End-Products Induce Apoptosis of Vascular Smooth Muscle Cells: A Mechanism for Vascular Calcification
por: Koike, Sayo, et al.
Publicado: (2016)